Today
  • 06:41

    Asahi Kasei Therapeutics Announces FDA Approval of Hovilpri® (Pritelivir) Tablets for Mucocutaneous Hsv Lesions Refractory (With or Without Resistance) to Standard Antiviral Treatment in Immunocompromised Adults

    06:35

    ME Therapeutics Extends Option Agreement for Cd22 Nanobody Asset

    06:31

    Exclusive - Sequoia-Backed Startup Nuvacore Is Raising Hundreds of Millions of Dollars at a Roughly $2.5 Billion Valuation, Sources Say

    06:20

    Fcpt Announces Acquisition via Sale-Leaseback of an Automotive Service Property for $2.3 Million

    06:17

    Russian Envoy Dmitriev During Visit to Washington Asked for Licenses to Export Diesel to US Market to Be Granted to All Russia's Major Oil Firms, Sources Familiar With the Situation Said

    06:06

    Super Micro Contractor Pleads Guilty in Scheme to Divert Computer Servers Built With Nvidia AI Chips to China, According to Court Docket

    06:00

    Orca Energy Group: Paet Is Willing to Continue Operating Songo Songo Facilities Under Existing Licence and Psa Framework for 60-Day Statutory Period

    06:00

    Orca Energy Group - Paet Proposes Transition Working Group With Tpdc and Songas for Transition Planning

    06:00

    Orca Energy Group - Fcc Prohibits Merger Application Relating to Proposed Deal on Oct 5, 2026

    06:00

    Orca Energy Group Provides Update on Songo Songo Licence, Operations, and the Proposed Transaction

    06:00

    Orca Energy Group - Paet Rejects Proposed Licence Extension Terms as Uneconomic and Unacceptable on Oct 9, 2026

    06:00

    Mindwave Innovations Signs 3 Client Network Agreements in 10 Days, Extending Mindchain Into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required Nyse American Disclosure

    05:50

    Brazil's Cury: Cyrela Cuts Stake in the Company to 14.97% - Filing

    05:50

    Nasdaq Says Short Interest Rose 2.99% in Late September From Mid-September

    05:48

    Kalshi Probes Bets on Trump’s Pick for New White House Press Secretary - WSJ

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10